+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

VITRAKVI Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

VITRAKVI Market Drug Insight and Market Forecast - 2032

  • Report
  • February 2023
  • 30 Pages
  • Global
From
From
Chemotherapy Induced Diarrhea - Epidemiology Forecast - 2032 - Product Thumbnail Image

Chemotherapy Induced Diarrhea - Epidemiology Forecast - 2032

  • Report
  • February 2023
  • 60 Pages
  • Global
From
United States KISQALI Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

United States KISQALI Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • United States
From
IBRANCE Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

IBRANCE Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
AFINITOR Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

AFINITOR Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
Benralizumab Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Benralizumab Emerging Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
From
Head and Neck Cancer (HNC) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Head and Neck Cancer (HNC) - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 116 Pages
  • Global
From
Cholangiocarcinoma (CCA) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Cholangiocarcinoma (CCA) - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 162 Pages
  • Global
From
From
Gazyva Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Gazyva Emerging Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
From
Low-Grade Glioma - Epidemiology Forecast-2032 - Product Thumbnail Image

Low-Grade Glioma - Epidemiology Forecast-2032

  • Report
  • August 2022
  • 80 Pages
  • Global
From
Brain Cancer - Epidemiology Forecast - 2032 - Product Thumbnail Image

Brain Cancer - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Waldenstrom Macroglobulinemia - Epidemiology Forecast to 2032 - Product Thumbnail Image

Waldenstrom Macroglobulinemia - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
From
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more